Medication info
Duvimet SR Tablets 0.5/100/1000 Milligrams

Duvimet SR Tablets 0.5/100/1000 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletLobeglitazone Sulfate›0.5mg / 1 tabletSitagliptin Phosphate Hydrate›128.5mg / 1 tablet
Manufacturer / importer
JongKundang Co., Ltd.
Appearance
Blue, oval-shaped, bi-convex, sustained-release film-coated tablet
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 6 tablets/bottle
Approval status
Active

MFDS item code 202301430 · Approved 2023.05.02 · Insurance code 643309330

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For antidiabetic therapy, the recommended dose of this medicine is lobeglitazone sulfate 0.5 mg and sitagliptin 100 mg; the dose of extended-release metformin hydrochloride should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it. Take 1 tablet of this medicine 0.5/100/1000 mg extended-release tablet once daily. Patients taking this medicine 0.25/50/500 mg, 0.25/50/750 mg, or 0.25/50/1000 mg extended-release tablets should take 2 tablets together once daily. If adequate glycemic control cannot be achieved with metformin and sitagliptin, the starting dose of this medicine should be lobeglitazone sulfate 0.5 mg, sitagliptin 100mg, and the dose of metformin hydrochloride currently being taken, or an appropriate dose therapeutically equivalent to it. For patients switching from combination therapy with lobeglitazone, sitagliptin, and metformin to this medicine, the dose of this medicine should be the existing dose of each component. No dose adjustment is necessary in patients with mild renal impairment [estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2]. In patients with moderate renal impairment [CKD stage 3A, estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60 mL/min/1.73m2], this medicine may be used by adjusting the metformin hydrochloride dose if it is well tolerated and there are no other conditions that may increase the risk of lactic acidosis. Since the starting dose of extended-release metformin hydrochloride is 500mg or 750 mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or estimated glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73m2, respectively, administration of this medicine should be discontinued immediately.

Ingredients

Manufacturer
JongKundang Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

View approved original text

This medication helps improve blood sugar control in adult patients with type 2 diabetes by combining Rosiglitazone, Sitagliptin, and Metformin. It effectively supports blood sugar management when used alongside dietary and exercise therapy, thus improving the blood sugar control of patients.

How to take

Adult dose

For antidiabetic therapy, the recommended dose of this medicine is lobeglitazone sulfate 0.5 mg and sitagliptin 100 mg; the dose of extended-release metformin hydrochloride should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it. Take 1 tablet of this medicine 0.5/100/1000 mg extended-release tablet once daily. Patients taking this medicine 0.25/50/500 mg, 0.25/50/750 mg, or 0.25/50/1000 mg extended-release tablets should take 2 tablets together once daily. If adequate glycemic control cannot be achieved with metformin and sitagliptin, the starting dose of this medicine should be lobeglitazone sulfate 0.5 mg, sitagliptin 100mg, and the dose of metformin hydrochloride currently being taken, or an appropriate dose therapeutically equivalent to it. For patients switching from combination therapy with lobeglitazone, sitagliptin, and metformin to this medicine, the dose of this medicine should be the existing dose of each component. No dose adjustment is necessary in patients with mild renal impairment [estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2]. In patients with moderate renal impairment [CKD stage 3A, estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60 mL/min/1.73m2], this medicine may be used by adjusting the metformin hydrochloride dose if it is well tolerated and there are no other conditions that may increase the risk of lactic acidosis. Since the starting dose of extended-release metformin hydrochloride is 500mg or 750 mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or estimated glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73m2, respectively, administration of this medicine should be discontinued immediately.

Precautions

This medication contains Rosiglitazone, which can place a strain on the heart, and should not be used in patients with heart failure or those showing symptoms of heart failure. Symptoms of heart failure include sudden weight gain, shortness of breath, and edema; if these occur, medical attention should be sought immediately. Additionally, the Sitagliptin component may rarely cause severe allergic reactions or acute pancreatitis, so patients experiencing symptoms such as skin rash or abdominal pain should visit a hospital immediately. The Metformin component may rarely cause a serious metabolic disorder known as lactic acidosis; thus, patients with impaired kidney function or liver disease should avoid this medication. If symptoms such as vomiting, diarrhea, abdominal pain, or fatigue occur, patients should consult a physician immediately. This medication should not be administered to patients with impaired kidney or liver function, heart failure, acute infections, or those scheduled for major surgery. If such conditions arise, the medication should be discontinued and healthcare professionals should be consulted. Regular blood tests and liver function tests should be conducted during treatment, and patients should notify their healthcare providers immediately if they experience sudden weight gain or symptoms such as edema and shortness of breath. Moreover, this medication carries a risk of hypoglycemia; therefore, patients should avoid skipping meals or engaging in excessive physical activity and should closely monitor blood sugar changes when used in combination with other diabetes medications. Women who are pregnant or planning to become pregnant must consult a physician, and premenopausal women should use appropriate contraceptive methods as ovulation may be stimulated. Lastly, excessive alcohol consumption should be avoided during the course of this medication, and if scheduled for a radiocontrast examination, drug use should be discontinued for a certain period before and after the test.

Side effects

  • Congestive heart failure
  • excessive and rapid weight change
  • dyspnea
  • edema
  • severe hypersensitivity reaction
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • severe lactic acidosis
Show 208 more
  • hypoglycemia
  • nasopharyngitis
  • headache
  • dyspepsia
  • abdominal pain
  • edema
  • dental caries
  • dental disease
  • constipation
  • diarrhea
  • heartburn
  • cold
  • upper respiratory tract infection
  • cough
  • hyperlipidemia
  • pruritus
  • osteoarthritis
  • myalgia
  • fracture
  • arthralgia
  • hematuria
  • increased ALT
  • increased AST
  • fatty liver
  • dizziness
  • paresthesia
  • diabetic retinopathy
  • palpitations
  • hypertension
  • anemia
  • herpes zoster
  • breast discomfort
  • weight gain
  • chronic gastritis
  • gastroesophageal reflux disease
  • diabetic retinopathy
  • hyperglycemia
  • tinnitus
  • insomnia
  • atherosclerosis
  • weight loss
  • leg pain
  • leg edema
  • back pain
  • lack of efficacy
  • rhinitis
  • pneumonia
  • neuropathy
  • facial edema
  • vomiting
  • gastrointestinal discomfort
  • gastroenteritis
  • oral ulcer formation
  • blood in stool
  • epigastric discomfort
  • loose stools
  • erosive gastritis
  • peritonitis
  • esophagitis
  • worsening dysphagia
  • gastric ulcer
  • oral ulcer formation
  • gingivitis
  • appendicitis
  • periodontitis
  • hemorrhoids
  • exacerbation of hemorrhoids
  • toothache
  • exacerbation of hypercholesterolemia
  • increase in fasting blood sugar
  • increase in glycosylated hemoglobin
  • vitamin D deficiency
  • dyslipidemia
  • increased low-density lipoprotein
  • pelvic pain
  • periorbital edema
  • worsening edema
  • syncope
  • flank pain
  • low back pain
  • generalized edema
  • generalized weakness
  • acute respiratory distress syndrome
  • bronchitis
  • chronic obstructive pulmonary disease
  • chronic laryngitis
  • throat infection
  • atelectasis
  • sinusitis
  • shortness of breath
  • asthma exacerbation
  • nosebleed
  • dyspnea
  • pulmonary edema
  • epiglottitis
  • multiple neuropathy
  • cognitive impairment
  • skin numbness
  • brainstem ischemia
  • eye twitching
  • leg cramps
  • simple partial seizure
  • peripheral sensory neuropathy
  • speech disturbance
  • worsening dizziness
  • spinal canal stenosis
  • cystitis
  • nocturia
  • increased blood creatinine
  • dysuria
  • frequent urination
  • nephrotic syndrome
  • ureteral stone
  • urinary tract infection
  • rib fracture
  • shoulder impingement syndrome
  • osteoporotic fracture
  • pelvic fracture
  • joint abnormalities
  • costochondritis
  • leg fracture
  • temporomandibular joint dysfunction
  • elbow deformity
  • tinea corporis
  • keratosis
  • psoriasis
  • exacerbation of psoriasis
  • acute urticaria
  • tinea unguium
  • trichotillomania
  • onychomycosis
  • alopecia
  • skin nodules
  • skin peeling
  • dermographism
  • erythematous rash
  • corneal deposits
  • conjunctivitis
  • high intraocular pressure
  • duct obstruction
  • chorioretinal disorder
  • cataract
  • exacerbation of cataract
  • decreased vision
  • eye infection
  • erythrocytosis
  • erectile dysfunction
  • anxiety response
  • depression
  • depressed mood
  • mental disorder
  • confusion
  • skin laceration
  • knee arthroplasty
  • intervertebral disc herniation
  • dry eye syndrome
  • toxocariasis
  • genital moniliasis
  • vaginal candidiasis
  • increased TSH
  • hyperthyroidism
  • sialadenitis
  • vaginitis
  • cervical dysplasia
  • menopausal symptoms
  • intermittent claudication
  • subdural hematoma
  • aortic atherosclerosis
  • gallstones
  • cholangitis
  • coronary artery disease
  • coronary artery occlusion
  • male perineal pain
  • atrial fibrillation
  • ventricular premature contraction
  • cerebral aneurysm
  • disciform erythema lupus
  • bruise
  • macular edema
  • osteoarthritis
  • myalgia
  • fracture
  • arthralgia
  • anemia
  • increased ALT
  • increased AST
  • fatty liver
  • dizziness
  • diabetic retinopathy
  • hyperglycemia
  • edema
  • headache
  • nasopharyngitis
  • hypoglycemia
  • acute pancreatitis
  • hypersensitivity reaction
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • lactic acidosis
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • appetite loss
  • erythema
  • urticaria
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture and should be stored in a tightly closed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage preserves the effectiveness and safety of the medication for a longer duration.

Appearance and packaging

Appearance

Blue, oval-shaped, bi-convex, sustained-release film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 6 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.